Receptor tyrosine kinase inhibitors in cancer
Nasim Ebrahimi, Elmira Fardi, Hajarossadat Ghaderi, Sahar Palizdar, Roya Khorram, Reza Vafadar, Masoud Ghanaatian, Fatemeh Rezaei‐Tazangi, Payam Baziyar, Amirhossein Ahmadi, Michael R. Hamblin, Amir Reza Aref
Topics & Concepts
Receptor tyrosine kinaseCancer researchTyrosine kinaseCancerReceptor Protein-Tyrosine KinasesTargeted therapyDrugImmunotherapyDrug developmentMedicineReceptorBiologyPharmacologyInternal medicineHER2/EGFR in Cancer ResearchCancer Mechanisms and TherapyPI3K/AKT/mTOR signaling in cancer